The ability of psychedelics to alter structural and functional neuroplasticity in the brain is a significant area of exploration for labs around the world. Researchers are teasing apart the fine details of the mechanisms by which compounds like psilocybin (the prodrug of psilocin found in magic mushrooms) can relieve anxiety, depression, and other symptoms while maintaining their effects for weeks…


Previous articleAwakn Life Sciences Begins Trading on the OTCQB(R) Venture Market Under the Symbol ‘AWKNF’ on August 12th
Next articleFilament Health Announces Q2 2021 Financial Results